The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((1-benzyl-4-(naphthalen-2-ylmethyl)piperidin-4-yl)methyl)-2-guanidinoacetamide ID: ALA3361435
Chembl Id: CHEMBL3361435
PubChem CID: 118724994
Max Phase: Preclinical
Molecular Formula: C27H33N5O
Molecular Weight: 443.60
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)NCC(=O)NCC1(Cc2ccc3ccccc3c2)CCN(Cc2ccccc2)CC1
Standard InChI: InChI=1S/C27H33N5O/c28-26(29)30-18-25(33)31-20-27(17-22-10-11-23-8-4-5-9-24(23)16-22)12-14-32(15-13-27)19-21-6-2-1-3-7-21/h1-11,16H,12-15,17-20H2,(H,31,33)(H4,28,29,30)
Standard InChI Key: KWCCRLUVBBXLLW-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 443.60Molecular Weight (Monoisotopic): 443.2685AlogP: 3.26#Rotatable Bonds: 8Polar Surface Area: 94.24Molecular Species: BASEHBA: 3HBD: 4#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 11.11CX LogP: 3.09CX LogD: -0.92Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.32Np Likeness Score: -0.61
References 1. Journigan VB, Mésangeau C, Vyas N, Eans SO, Cutler SJ, McLaughlin JP, Mollereau C, McCurdy CR.. (2014) Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptors., 57 (21): [PMID:25268943 ] [10.1021/jm500989n ]